Zusammenfassung
Die Prüfung der klinischen Wirksamkeit von Arzneimitteln im Indikationsgebiet der akuten Bronchitis unterliegt mehreren Zwängen, aber auch Fallgruben.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Leiner S (1994) Vital and health statistics: current estimates from the National Health Interview Survey, 1993. Series 10: data from the National Health Survey No. 190. US Department of Health and Human Services, Hyattsville, MD, pp 13–19
Gwaltney JM Jr (1995) Acute bronchitis. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases, 4th edn. Churchill Livingstone, New York, pp 606–608
Perlman PE, Ginn DR (1990) Respiratory infections in ambulatory adults. Choosing the best treatment. Postgrad Med 87(1):175–184
Williamson HA Jr (1984) A randomized, controlled trial of doxycycline in the treatment of acute bronchitis. J Fam Pract 19(4):481–486
Gonzales R, Sande M (1995) What will it take to stop physicians from prescribing antibiotics in acute bronchitis [editorial]? Lancet 345:665–666
Nicholson KG (1992) Clinical features of influenza. Sem Resp Infect 7:26–37
Anderson LJ, Patriarca PA, Hierholzer JC et al (1983) Viral respiratory illness. Med Clin North Am 67:1009–1030
Arzneimittelkommission der Deutschen Ärzteschaft (1999) Empfehlungen zur Therapie akuter Infekte der oberen Atemwege und Bronchitiden. AVP-Sonderheft Therapieempfehlungen, 1. Aufl Dezember 1999, S 1–17
Falck G, Heyman L, Gnarpe J, Gnarpe H (1994) Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis. Scand J Infect Dis 26:179–187
Hueston WJ, Mainous AG IIIrd (1998) Acute Bronchitis. Am Fam Physician Mar 15, 57(6):1270–1276, 1281-1282
Kolmos HJ, Little P (1999) Controversies in management. Should general practitioners perform diagnostic tests on patients before prescribing antibiotics? BMJ 318:799–802
Müller T-R (1996) Infektionen des mittleren und unteren Respirationstraktes. In: Vogel F (Hrsg) Respiratorische Infektionen, 2. Aufl. Kohlhammer, Stuttgart Berlin Köln, S 23
Jónsson JS, Gíslason T, Gíslason D, Sigurdsson JA (1998) Acute bronchitis and clinical outcome three years later: prospective cohort study. BMJ 317:1433–1440
Macfarlane JT, Holmes WF, Macfarlane RM, Lewis S (1997) Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in primary care in the UK: implications for developing management guidelines. Respir Med 91:427–434
Howie JGR (1973)A new look at respiratory illness in general practice. A reclassification of respiratory illness based on antibiotic prescribing. J R Coll Gen Pract 23: 895–904
Macfarlane J, Holmes W, Macfarlane R, Britten N (1997) Influence of patients’ expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. BMJ 315:1211–1214
Verheij TJM, Kaptein AA, Mulder JD (1989) Acute bronchitis: aetiology, symptoms and treatment. Fam Pract 6:66–69
Orr PH, Scherer K, Macdonald A, Moffatt MEK (1993) Randomized placebo-controlled trials of antibiotics for acute bronchitis: a critical review of the literature. J Fam Pract 36:507–512
Stott NC, West RR (1976) Randomised controlled trial of antibiotics in patients with cough and purulent sputum. Br Med J 2(6035):556–559
Brickfield FX, Carter WH, Johnson RE (1986) Erythromycin in the treatment of acute bronchitis in a community practice. J Fam Pract 23(2): 119–122
Dunlay J, Reinhardt R, Roi LD (1987) A Placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis. J Fam Pract 25(2): 137–141
King DE, Williams WC, Bishop L, Shechter A (1996) Effectiveness of erythromycin in the treatment of acute bronchitis. J Fam Pract 42(6):601–605
Franks P, Gleiner JA (1984) The treatment of acute bronchitis with trimethoprim and sulfamethoxazole. J Fam Pract 19(2):185–190
Becker L, Glazier R, Mclsaac W, Smucny J (1999) Antibiotics for acute bronchitis (Cochrane Review). In: The Cochrane Library, issue 4, pp 1–16
Belongia EA, Schwartz B (1998) Strategies for promoting judicious use of antibiotics by doctors and patients. BMJ 317:668–671
Huovinen P, Cars O (1998) Editorials-Control of antimicrobial resistance: time for action. BMJ 317:613–614
Wise R, Hart T, Cars O, Streulens M, Helmuth R, Houvinen P et al (1998) Antimicrobial resistance is a major threat to public health. BMJ 317:609–610
Mainous AG, Zoorob RJ, Oler MJ, Haynes OM (1997) Patient knowledge of upper respiratory infections: implications for antibiotic expectations and unnecessary utilization. J Fam Pract 45(l):75–83
Chan CS (1996) What do patients expect from consultations for upper respiratory tract infections? Fam Pract 13:229–235
Britten N (1995) Patients’ demands for prescriptions in primary care. Patients cannot take all the blame for over prescribing. BMJ 310:1084–1085
Webb S, Lloyd M (1994) Prescribing and referral in general practice: a study of patients’ expectations and doctors’ actions. Br J Gen Pract 44:165–169
Rapaport J (1979) Patients’ expectations and intention to self medicate. J R Coll Gen Pract 29:468–472
Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N (1998) Understanding the culture of prescribing: qualitative study of general practitioners’ and patients’ perceptions of antibiotics for sore throats. BMJ 317:637–642
Bradley CP (1992) Uncomfortable prescribing decisions: a critical incident study. BMJ 304:294–296
Armstrong D, Reyburn H, Jones R (1996) A study of general practitioners’ reasons for changing their prescribing behaviour. BMJ 312:949–952
Mainous AG, Hueston WJ, Eberlein C (1997) Colour of respiratory discharge and antibiotic use. Lancet 350:1077
Schwartz RH, Freij BJ, Ziai M, Sheridan MJ (1997) Antimicrobial prescribing for acute purulent rhinitis in children: a survey of pediatricians and family practitioners. Pediatr Infect Dis J 16:185–190
Dowell SF (1998) Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics 101 (supp;l 1):163–184
Otitis Media Guideline Panel (1994) Clinical practice guideline: otitis media with effusion in young children (report no 94-0622). Agency for Health Care Policy and Research, Rockville, MD
Bisno AL, Gerber MA, Gwaltney JM, Kaplan AL, Schwartz RH (1997) Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Clin Infect Dis 25:574–583
Mclsaac WJ, Goel V (1996) Sore throat management practices of Canadian family physicians. Fam Pract 14(l):34–39
Grimshaw JM, Russell IT (1993) Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342:317–322
Davis DA, Thomson MA, Oxmen AD, Haynes RB (1995) Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA 274:700–705
Bain DJG (1983). Papers that have changed my practice. Diagnostic behaviour and prescribing. BMJ 287:1269–1270
Little P, Williamson I, Warner G, Gould C, Gantley M, Kinmouth AL (1997) Open randomised trial of prescribing strategies in managing sore throat. BMJ 314:722–727
Hamm RM, Hicks RJ, Bemben DA (1996) Antibiotics and respiratory infections: are patients more satisfied when expectations are met? J Fam Pract 43:56–62
Schwartz B, Bell DM, Hughes JM (1997) Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. JAMA 278:944–945
Soumerai S, Avorn J (1990) Principles of educational outreach (”academic detailing”) to improve clinical decision making. JAMA 263:549–556
Schaffner W, Ray W, Federspiel C, Miller W (1983) Improving antibiotic prescribing in office practice. JAMA 250:1728–1732
Ekedahl A, Andersson S, Hovelius B, Molstad S, Lidholm H, Melandor A (1995) Drug prescription attitudes and behaviour of general practitioners. Effects of a problem oriented educational programme. Eur J Clin Pharmacol 47:381–387
De Santis G, Harvey K, Howard D, Mashford M, Moulds R (1994) Improving the quality of antibiotic prescription patterns in general practice. Med J Aust 160:502–505
Avorn J, Soumerai S (1983) Improving drug-therapy decisions through educational outreach. N Engl J Med 308:1457–1463
Schoenbaum SC (1993) Feedback of clinical practice information. HMO Pract 7:5–11
Macfarlane J, Holmes WF, Macfarlane RM (1997) Reducing reconsultations for acute lower respiratory tract infection with an information leaflet. Br J Gen Pract 47: 719–722
Howie JGR, Hutchison KR (1987) Antibiotics and respiratory illness in general practice: prescribing policy and work load. BMJ ii:1342
Holmes WF, Macfarlane JT, Macfarlane RM, Lewis S (1997) The influence of antibiotics and other factors on reconsultation for acute lower respiratory tract illness in primary care. Br J Gen Pract, Dec 47(425):815–818
Hueston WJ (1991) A comparison of albuterol and erythromycin for the treatment of acute bronchitis. J Fam Pract 33(5):476–480
Hueston WJ (1994) Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract 39(5):437–440
Melbye H, Aasebo U, Straume B (1991) Symptomatic effect of inhaled fenoterol in acute bronchitis: a placebo-controlled double-blind study. Fam Pract 8(3):216–222
Williamson HA (1987) Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction. J Fam Pract 25:251–256
Tukiainen PK (1986) The treatment of acute transient cough: a placebo-controlled comparison of dextromethorphan and dextromethorphans-β2-sympathomimetic combination. Eur J Respir Dis 69:95–99
Littenberg B, Wheeler M, Smith DS (1996) A randomized controlled trial of oral albuterol in acute cough. J Fam Pract 42:49–53
Nelson HS (1995) β-Adrenergic bronchodilators. N Engl J Med 333:499–506
Jürgens UR, Stöber M, Vetter H (1998) Steroidartige Hemmung des monozytären Arachidonsäuremetabolismus und der IL-lβ-Produktion durch 1.8-Cineol. Atemw-Lungenkrkh 24:3–11
Beuscher N, Kietzmann M, Bien E, Champeroux P (1998) Interference of Myrtol standardised with inflammatory and allergic mediators. Arzneim-Forsch/Drug Res 48(1): 985–989
Graβmann J, Hippeli S, Dornisch K, Rohnert U, Beuscher N, Elstner EF (2000) Antioxidant properties of essential oils. Arzneim-Forsch/Drug Res 50(I):135–139
Hippeli S et al (2000) Freie Radikale in Pathogenese und Therapie Von entzündlichen Erkrankungen des Bronchialsystems. In: Meister R (Hrsg) Entzündliche Erkrankungen des Bronchialsystems, 1. Aufl. Springer, Heidelberg, S 1–25
Beuscher N, Bien E, Elstner EF, Kietzmann M, Amon UE (1997) Myrtol standardized in treatment of sinusitis and bronchitis-pharmacodynamics and pharmacokinetics. Z Phytotherapie, Abstractband, 8. Phytotherapiekongress Würzburg, S 9–10
Meister R, Wittig T, Beuscher N, de Mey C (1999) Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis: a double-blind, placebo-controlled study. Arzneim Forschung/Drug Res 49:351–358
Matthys H, de Mey C, Carls C, Rys A, Geib A, Wittig T (2000) Efficacy and tolerability of myrtol stand, in acute bronchitis-A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs Placebo vs Cefuroxime vs Ambroxol. Arzneim Forsch/Drug Res 50:700–711
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
De Mey, C., Wittig, T. (2002). Myrtol standardisiert und Antibiotika in der Behandlung der akuten Bronchitis — eine randomisierte, doppelblinde Multizenterstudie. In: Schulz, V., Rietbrock, N., Roots, I., Loew, D. (eds) Phytopharmaka VII. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57528-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-57528-0_3
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-642-63286-0
Online ISBN: 978-3-642-57528-0
eBook Packages: Springer Book Archive